Innovating Excellence in API Manufacturing & CDMOs

With over 35 years of expertise, Marvel Drugs Pvt. Ltd. delivers high-quality Active Pharmaceutical Ingredients, Advanced Drug Intermediates, and Contract Research & Manufacturing Services for the global pharmaceutical industry.

About Us

Marvel Drugs Pvt. Ltd. is a fast-growing API manufacturing Company and CDMO with over 35 years of experience, We are a manufacturer of APIs, Advance Drug Intermediates and offer Contract Development and Manufacturing Services for Pharmaceuticals.

Our company specializes in the synthesis of niche APIs and excels in the production of multi-step complex molecules. R&D and Quality are two areas of strength that the company prides itself on.

We have established a strong presence with global pharmaceutical companies, with a focus on developed markets. While most of our customers are in Europe, we are also growing our client base in China, South America and India.

Our commitment is to provide extremely high-quality products as per client needs, competitive prices, reliable delivery schedules, and constant technological upgradation.

Since 2014, Marvel Drugs has embarked on an ambitious goal for growth. We aim to become one of the top 25 CDMO players in India within the next 5 years. To achieve this, we target the development and commercial launch of 5 major new molecules a year and are looking for world-class talent who is eager to be part of that journey.

We maintain strong partnerships with leading academic institutions to drive advanced product development.

Our Vision

To be a globally respected, pharmaceutical company, delivering high-quality Active Pharmaceutical Ingredients (APIs) and Contract Research and Manufacturing Services (CRAMS).

Our Mission

To invest in R&D, process development, and quality systems that ensure excellence and compliance.

To expand our global footprint by serving clients across the globe with reliability and trust.

To uphold the highest standards of manufacturing through WHO GMP certification and continuous improvement.